vs
多邻国（DUOL）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
多邻国的季度营收约是REPLIGEN CORP的1.4倍（$282.9M vs $197.9M），多邻国净利率更高（14.8% vs 6.7%，领先8.1%），多邻国同比增速更快（35.0% vs 13.6%），多邻国自由现金流更多（$96.6M vs $17.6M），过去两年多邻国的营收复合增速更高（29.9% vs 14.4%）
多邻国是全球知名教育科技企业，提供覆盖40余种语言的免费及付费游戏化自适应学习课程，同时推出官方语言能力认证、数学学习、扫盲教育等服务，面向个人用户、教育机构及企业客户提供多元学习解决方案。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
DUOL vs RGEN — 直观对比
营收规模更大
DUOL
是对方的1.4倍
$197.9M
营收增速更快
DUOL
高出21.3%
13.6%
净利率更高
DUOL
高出8.1%
6.7%
自由现金流更多
DUOL
多$79.0M
$17.6M
两年增速更快
DUOL
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $282.9M | $197.9M |
| 净利润 | $42.0M | $13.3M |
| 毛利率 | 72.8% | 52.5% |
| 营业利润率 | 15.4% | 9.0% |
| 净利率 | 14.8% | 6.7% |
| 营收同比 | 35.0% | 13.6% |
| 净利润同比 | 201.7% | 143.9% |
| 每股收益（稀释后） | $0.99 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DUOLRGEN
| Q4 25 | $282.9M | $197.9M | ||
| Q3 25 | $271.7M | $188.8M | ||
| Q2 25 | $252.3M | $182.4M | ||
| Q1 25 | $230.7M | $169.2M | ||
| Q4 24 | $209.6M | $174.1M | ||
| Q3 24 | $192.6M | $154.9M | ||
| Q2 24 | $178.3M | $154.1M | ||
| Q1 24 | $167.6M | $151.3M |
净利润DUOLRGEN
| Q4 25 | $42.0M | $13.3M | ||
| Q3 25 | $292.2M | $14.9M | ||
| Q2 25 | $44.8M | $14.9M | ||
| Q1 25 | $35.1M | $5.8M | ||
| Q4 24 | $13.9M | $-30.3M | ||
| Q3 24 | $23.4M | $-654.0K | ||
| Q2 24 | $24.4M | $3.3M | ||
| Q1 24 | $27.0M | $2.1M |
毛利率DUOLRGEN
| Q4 25 | 72.8% | 52.5% | ||
| Q3 25 | 72.5% | 53.2% | ||
| Q2 25 | 72.4% | 50.0% | ||
| Q1 25 | 71.1% | 53.6% | ||
| Q4 24 | 71.9% | 26.1% | ||
| Q3 24 | 72.9% | 50.0% | ||
| Q2 24 | 73.4% | 49.8% | ||
| Q1 24 | 73.0% | 49.5% |
营业利润率DUOLRGEN
| Q4 25 | 15.4% | 9.0% | ||
| Q3 25 | 12.9% | 8.9% | ||
| Q2 25 | 13.2% | 7.6% | ||
| Q1 25 | 10.2% | 3.9% | ||
| Q4 24 | 6.6% | -17.7% | ||
| Q3 24 | 7.0% | -5.1% | ||
| Q2 24 | 10.5% | 1.0% | ||
| Q1 24 | 9.8% | 1.3% |
净利率DUOLRGEN
| Q4 25 | 14.8% | 6.7% | ||
| Q3 25 | 107.5% | 7.9% | ||
| Q2 25 | 17.8% | 8.2% | ||
| Q1 25 | 15.2% | 3.4% | ||
| Q4 24 | 6.6% | -17.4% | ||
| Q3 24 | 12.1% | -0.4% | ||
| Q2 24 | 13.7% | 2.2% | ||
| Q1 24 | 16.1% | 1.4% |
每股收益（稀释后）DUOLRGEN
| Q4 25 | $0.99 | $0.24 | ||
| Q3 25 | $5.95 | $0.26 | ||
| Q2 25 | $0.91 | $0.26 | ||
| Q1 25 | $0.72 | $0.10 | ||
| Q4 24 | $0.31 | $-0.55 | ||
| Q3 24 | $0.49 | $-0.01 | ||
| Q2 24 | $0.51 | $0.06 | ||
| Q1 24 | $0.57 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.3B | $2.1B |
| 总资产 | $2.0B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资DUOLRGEN
| Q4 25 | $1.0B | $767.6M | ||
| Q3 25 | $1.0B | $748.7M | ||
| Q2 25 | $976.2M | $708.9M | ||
| Q1 25 | $884.0M | $697.2M | ||
| Q4 24 | $785.8M | $757.4M | ||
| Q3 24 | $854.4M | $784.0M | ||
| Q2 24 | $888.2M | $809.1M | ||
| Q1 24 | $829.7M | $780.6M |
总债务DUOLRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DUOLRGEN
| Q4 25 | $1.3B | $2.1B | ||
| Q3 25 | $1.3B | $2.1B | ||
| Q2 25 | $977.0M | $2.1B | ||
| Q1 25 | $893.8M | $2.0B | ||
| Q4 24 | $824.5M | $2.0B | ||
| Q3 24 | $822.5M | $2.0B | ||
| Q2 24 | $766.9M | $2.0B | ||
| Q1 24 | $711.1M | $2.0B |
总资产DUOLRGEN
| Q4 25 | $2.0B | $2.9B | ||
| Q3 25 | $1.9B | $2.9B | ||
| Q2 25 | $1.5B | $2.9B | ||
| Q1 25 | $1.4B | $2.9B | ||
| Q4 24 | $1.3B | $2.8B | ||
| Q3 24 | $1.2B | $2.8B | ||
| Q2 24 | $1.1B | $2.9B | ||
| Q1 24 | $1.1B | $2.8B |
负债/权益比DUOLRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $107.3M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $96.6M | $17.6M |
| 自由现金流率自由现金流/营收 | 34.1% | 8.9% |
| 资本支出强度资本支出/营收 | 3.8% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.56× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $369.7M | $93.9M |
8季度趋势，按日历期对齐
经营现金流DUOLRGEN
| Q4 25 | $107.3M | $25.7M | ||
| Q3 25 | $84.2M | $48.1M | ||
| Q2 25 | $90.7M | $28.6M | ||
| Q1 25 | $105.6M | $15.0M | ||
| Q4 24 | $83.3M | $39.2M | ||
| Q3 24 | $56.3M | $49.3M | ||
| Q2 24 | $62.4M | $42.2M | ||
| Q1 24 | $83.5M | $44.7M |
自由现金流DUOLRGEN
| Q4 25 | $96.6M | $17.6M | ||
| Q3 25 | $79.4M | $43.4M | ||
| Q2 25 | $89.5M | $21.5M | ||
| Q1 25 | $104.3M | $11.4M | ||
| Q4 24 | $81.4M | $33.6M | ||
| Q3 24 | $53.1M | $42.3M | ||
| Q2 24 | $56.8M | $37.4M | ||
| Q1 24 | $82.1M | $36.4M |
自由现金流率DUOLRGEN
| Q4 25 | 34.1% | 8.9% | ||
| Q3 25 | 29.2% | 23.0% | ||
| Q2 25 | 35.5% | 11.8% | ||
| Q1 25 | 45.2% | 6.8% | ||
| Q4 24 | 38.8% | 19.3% | ||
| Q3 24 | 27.6% | 27.3% | ||
| Q2 24 | 31.9% | 24.3% | ||
| Q1 24 | 49.0% | 24.0% |
资本支出强度DUOLRGEN
| Q4 25 | 3.8% | 4.1% | ||
| Q3 25 | 1.8% | 2.5% | ||
| Q2 25 | 0.5% | 3.9% | ||
| Q1 25 | 0.6% | 2.1% | ||
| Q4 24 | 0.9% | 3.2% | ||
| Q3 24 | 1.7% | 4.5% | ||
| Q2 24 | 3.1% | 3.1% | ||
| Q1 24 | 0.8% | 5.5% |
现金转化率DUOLRGEN
| Q4 25 | 2.56× | 1.93× | ||
| Q3 25 | 0.29× | 3.23× | ||
| Q2 25 | 2.02× | 1.92× | ||
| Q1 25 | 3.01× | 2.57× | ||
| Q4 24 | 5.99× | — | ||
| Q3 24 | 2.41× | — | ||
| Q2 24 | 2.56× | 12.70× | ||
| Q1 24 | 3.10× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DUOL
| License And Service | $242.3M | 86% |
| Advertising | $20.2M | 7% |
| English Test | $10.3M | 4% |
| Other | $10.1M | 4% |
RGEN
暂无分部数据
